28371745|t|Homocysteine as a peripheral biomarker in bipolar disorder: A meta-analysis
28371745|a|Bipolar disorder (BD) is a psychiatric disorder with an uncertain aetiology. Recently, special attention has been given to homocysteine (Hcy), as it has been suggested that alterations in 1-carbon metabolism might be implicated in diverse psychiatric disorders. However, there is uncertainty regarding possible alterations in peripheral Hcy levels in BD. This study comprises a meta-analysis comparing serum and plasma Hcy levels in persons with BD and healthy controls. We conducted a systematic search for all eligible English and non-English peer-reviewed articles. Nine cross-sectional studies were included in the meta-analyses, providing data on 1547 participants. Random-effects meta-analysis showed that serum and plasma levels of Hcy were increased in subjects with BD in either mania or euthymia when compared to healthy controls, with a large effect size in the mania group (g=0.98, 95% CI: 0.8-1.17, P<0.001, n=495) and a small effect in the euthymia group (g=0.3, 95% CI: 0.11-0.48, P=0.002, n=1052). Our meta-analysis provides evidence that Hcy levels are elevated in persons with BD during mania and euthymia. Peripheral Hcy could be considered as a potential biomarker in BD, both of trait (since it is increased in euthymia), and also of state (since its increase is more accentuated in mania). Longitudinal studies are needed to clarify the relationship between bipolar disorder and Hcy, as well as the usefulness of peripheral Hcy as both a trait and state biomarker in BD.
28371745	0	12	Homocysteine	T116,T123	C0019878
28371745	18	28	peripheral	T082	C0205100
28371745	29	38	biomarker	T201	C0005516
28371745	42	58	bipolar disorder	T048	C0005586
28371745	62	75	meta-analysis	T062	C0920317
28371745	76	92	Bipolar disorder	T048	C0005586
28371745	94	96	BD	T048	C0005586
28371745	103	123	psychiatric disorder	T048	C0004936
28371745	132	141	uncertain	T033	C0087130
28371745	142	151	aetiology	T169	C1314792
28371745	199	211	homocysteine	T116,T123	C0019878
28371745	213	216	Hcy	T116,T123	C0019878
28371745	249	260	alterations	T078	C1515926
28371745	264	283	1-carbon metabolism	T044	C1158831
28371745	315	336	psychiatric disorders	T048	C0004936
28371745	356	367	uncertainty	T033	C0087130
28371745	387	398	alterations	T078	C1515926
28371745	402	412	peripheral	T082	C0205100
28371745	413	416	Hcy	T116,T123	C0019878
28371745	427	429	BD	T048	C0005586
28371745	454	467	meta-analysis	T062	C0920317
28371745	478	483	serum	T059	C1278080
28371745	488	505	plasma Hcy levels	T059	C1278165
28371745	509	516	persons	T098	C0027361
28371745	522	524	BD	T048	C0005586
28371745	529	545	healthy controls	T080	C2986479
28371745	562	572	systematic	T169	C0220922
28371745	573	579	search	T052	C1706202
28371745	588	596	eligible	T080	C1548635
28371745	621	643	peer-reviewed articles	T170	C2985503
28371745	650	673	cross-sectional studies	T062	C0010362
28371745	679	687	included	T169	C0332257
28371745	695	708	meta-analyses	T062	C0920317
28371745	710	719	providing	T052	C1999230
28371745	720	724	data	T078	C1511726
28371745	733	745	participants	T098	C0679646
28371745	747	761	Random-effects	T080	C1280500
28371745	762	775	meta-analysis	T062	C0920317
28371745	788	793	serum	T059	C1278080
28371745	798	818	plasma levels of Hcy	T059	C1278165
28371745	824	833	increased	T081	C0205217
28371745	837	845	subjects	T096	C0681850
28371745	851	853	BD	T048	C0005586
28371745	864	869	mania	T048	C0338831
28371745	873	881	euthymia	T048	C0948853
28371745	887	895	compared	T052	C1707455
28371745	899	915	healthy controls	T080	C2986479
28371745	930	941	effect size	T081	C0814843
28371745	949	954	mania	T048	C0338831
28371745	955	960	group	T098	C1257890
28371745	974	976	CI	T081	C0009667
28371745	1016	1022	effect	T080	C1280500
28371745	1030	1038	euthymia	T048	C0948853
28371745	1039	1044	group	T098	C1257890
28371745	1057	1059	CI	T081	C0009667
28371745	1094	1107	meta-analysis	T062	C0920317
28371745	1131	1154	Hcy levels are elevated	T033	C0920051
28371745	1158	1165	persons	T098	C0027361
28371745	1171	1173	BD	T048	C0005586
28371745	1181	1186	mania	T048	C0338831
28371745	1191	1199	euthymia	T048	C0948853
28371745	1201	1211	Peripheral	T082	C0205100
28371745	1212	1215	Hcy	T116,T123	C0019878
28371745	1225	1235	considered	T078	C0750591
28371745	1241	1250	potential	T080	C3245505
28371745	1251	1260	biomarker	T201	C0005516
28371745	1264	1266	BD	T048	C0005586
28371745	1276	1281	trait	T032	C0599883
28371745	1295	1304	increased	T081	C0205217
28371745	1308	1316	euthymia	T048	C0948853
28371745	1331	1336	state	T169	C1442792
28371745	1348	1356	increase	T169	C0442805
28371745	1365	1376	accentuated	T080	C1997416
28371745	1380	1385	mania	T048	C0338831
28371745	1388	1408	Longitudinal studies	T062	C0023981
28371745	1435	1447	relationship	T080	C0439849
28371745	1456	1472	bipolar disorder	T048	C0005586
28371745	1477	1480	Hcy	T116,T123	C0019878
28371745	1497	1507	usefulness	T080	C3827682
28371745	1511	1521	peripheral	T082	C0205100
28371745	1522	1525	Hcy	T116,T123	C0019878
28371745	1536	1541	trait	T032	C0599883
28371745	1546	1551	state	T169	C1442792
28371745	1552	1561	biomarker	T201	C0005516
28371745	1565	1567	BD	T048	C0005586